Send me a link:

*Text messaging rates may apply.

 Dow Down0.28% Nasdaq Down0.17%

Teva Pharmaceutical Industries Limited (TEVA)

-NYQ
54.30 0.43(0.79%) Jul 21, 4:03PM EDT
|After Hours : 54.30 0.00 (0.00%) Jul 21, 5:28PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income 1,269,000   1,963,000   2,759,000  
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,642,000  1,708,000  1,069,000  
Adjustments To Net Income(626,000)540,000  (297,000)
Changes In Accounts Receivables -   -   -  
Changes In Liabilities -   -   -  
Changes In Inventories -   -   -  
Changes In Other Operating Activities968,000  414,000  594,000  
Total Cash Flow From Operating Activities 3,237,000   4,572,000   4,134,000  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(1,031,000)(1,104,000)(1,053,000)
Investments(160,000)(201,000)(217,000)
Other Cash flows from Investing Activities44,000  171,000  (6,331,000)
Total Cash Flows From Investing Activities (1,147,000) (1,134,000) (7,601,000)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid(1,089,000)(855,000)(800,000)
Sale Purchase of Stock(406,000)(1,147,000)(903,000)
Net Borrowings(2,411,000)319,000  5,034,000  
Other Cash Flows from Financing Activities23,000  5,000  5,000  
Total Cash Flows From Financing Activities (3,883,000) (1,678,000) 3,336,000  
Effect Of Exchange Rate Changes(48,000)23,000  (21,000)
Change In Cash and Cash Equivalents (1,841,000) 1,783,000   (152,000)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.